Top Buy
| Wertpapier | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | 358,80 € | 419,64 € | 16,96 % |
| Neurocrine Bioscience | 31 | 0 | 2 | 0 | 126,20 € | 140,60 € | 11,41 % |
| Amicus Therapeutics Inc. | 7 | 0 | 1 | 0 | 9,15 € | 17,64 € | 92,76 % |
| Iovance Biotherapeutics Inc. | 20 | 3 | 1 | 0 | 8,35 € | 25,72 € | 208,02 % |
| Blueprint Medicines Corp | 2 | 0 | 0 | 0 | 96,98 € | - | - |
| Xencor Inc. | 10 | 1 | 0 | 0 | 21,80 € | 32,58 € | 49,44 % |
| Charles River Labs Intl | 10 | 0 | 0 | 0 | 195,70 € | 248,57 € | 27,02 % |
| Exelixis Inc. | 18 | 0 | 0 | 0 | 20,05 € | 26,01 € | 29,71 % |
| United Therapeutics | 19 | 0 | 0 | 0 | 244,80 € | 287,40 € | 17,40 % |
| Catalent Inc. | 1 | 0 | 0 | 0 | 49,61 € | 55,00 € | 10,86 % |
| Repligen Corp. | 13 | 0 | 0 | 0 | 135,40 € | 184,76 € | 36,45 % |
| Alnylam Pharmace. | 36 | 0 | 0 | 0 | 138,50 € | 236,30 € | 70,61 % |
| Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | 4,71 € | 4,62 € | -2,06 % |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | 1,20 € | 3,70 € | 209,62 % |
| Halozyme Therapeutics Inc. | 15 | 0 | 0 | 0 | 39,77 € | 47,17 € | 18,61 % |
| PTC Therapeutics Inc. | 15 | 8 | 0 | 1 | 33,00 € | 41,51 € | 25,80 % |
| Agios Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | 34,80 € | 38,99 € | 12,04 % |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 0 | 0 | 35,40 € | 84,74 € | 139,39 % |
| Novocure Ltd | 1 | 1 | 0 | 0 | 20,57 € | - | - |